Moradec LLC, founded in 2012 by Helen (Hongyuan) Mao, PhD, provides novel research tools. The company’s novel secondary antibody-drug conjugates (2°ADCs) are used as a research tools for pre-screening antibody leads as ADC candidates.
Moradec has formed a strategic alliance with Concortis Biosystems, a leading provider of custom toxin and linker synthesis and antibody conjugation services for developing next generation ADCs. Together, these two companies have accumulated in-depth knowledge of small molecule toxins and linkers.
11760 Sorrento Valley Rd, Suite R
San Diego, CA 92121
USAd
Web: Moradec, LLC
Advertisement #3 
Advertisement #4
